CONTACTStaffCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Don’t miss our latest news! Sign up today for our free newsletter.
Scroll To Top
By continuing to use our site, you agree to our Private Policy and Terms of Use.
A U.S.-led study concerning use of the anti-HIV drug Viread as a way to prevent sexually acquired HIV infections has run into opposition in Cameroon, where AIDS activists say the sex workers participating in the study are being victimized, Voice of America reports. Cameroon journalist Roger Taakam says the clinical trial came under fire last week when a French-produced TV documentary addressed the study and suggested that the lives of the sex workers were being put at risk. AIDS activists in the country also say the sex workers participating in the study were asked to sign a consent form in English that most of them didn't understand. "We are not sure that someone who wants to give his informed consent who wouldn't understand or read English could do so because the fact that we are bilingual doesn't mean all Cameroonians can speak and understand French and English," AIDS activist Calice Talom told Voice of America. AIDS activists also claim that the women in the study aren't being given proper counseling or condoms to protect them from HIV infection and that half of the study subjects are being given a placebo that offers no defense against the virus. Researchers in Cameroon say the study is being run according to strict ethical guidelines and that the sex workers are receiving HIV risk-reduction instruction. They also say the drug is being similarly tested in Atlanta and San Francisco among high-risk populations, including sexually active gay men. Cameroon's government is now reportedly reviewing whether the trial is following ethical guidelines established when it started in June 2004. The Viread trials are aiming to evaluate the effectiveness of the anti-HIV drug in preventing HIV infections when taken daily by high-risk groups. Animal studies showed that the medication, when taken before sexual exposure to HIV or up to 24 hours after exposure, can prevent the virus from taking hold in the body.
COMING UP SOON ON THE ADVOCATE CHANNEL:
Watch the untold LGBTQ+ stories of NEW HOPE, PA!
Five short documentaries that capture the diversity & rich history of its deeply rooted LGBTQ+ community.
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Lauren Boebert Caught Fondling Date’s Genitals During Family-Friendly Musical: Video
September 15 2023 11:20 PM
Don’t miss our latest news! Sign up today for our free newsletter.
Watch Now: Advocate Channel
Trending Stories & News
For more news and videos on advocatechannel.com, click here.
Trending Stories & News
For more news and videos on advocatechannel.com, click here.
Latest Stories
Remembering the Height of AIDS Through a Young Person's Eyes in New Art Exhibit
November 03 2023 3:46 PM
Out's Deal Guide: Grab Your 50% Off Amazon Fire Tablets & More Recommended Deals on Amazon Today!
November 03 2023 3:42 PM
Experts Weigh in on the Realities of Gender-Affirming Care and the Dangers of Disinformation
November 03 2023 11:40 AM
Danica Roem Is Letting Her Record Speak for Itself as She Runs for Virginia Senate
November 03 2023 11:30 AM
Speaker Mike Johnson Once Tried to Stop a Queer Woman From Adopting Her Wife's Child
November 03 2023 9:25 AM